This company has been marked as potentially delisted and may not be actively trading.

Cross Country Healthcare (CCRN) Stock Forecast & Price Target

Get the Latest News and Ratings for CCRN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cross Country Healthcare and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CCRN Analyst Ratings Over Time

Type	Current Forecast 8/29/25 to 8/29/26	1 Month Ago 7/30/25 to 7/30/26	3 Months Ago 5/31/25 to 5/31/26	1 Year Ago 8/29/24 to 8/29/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$12.05	$12.05	$12.72	$17.93
Forecasted Upside	-9.06% Downside	-9.06% Downside	-2.83% Downside	34.01% Upside
Consensus Rating	Reduce	Reduce	Reduce	Hold

CCRN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CCRN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cross Country Healthcare Stock vs. The Competition

Type	Cross Country Healthcare	Healthcare Companies	Broader Market
Consensus Rating Score	1.90	2.30	2.53
Consensus Rating	Reduce	Hold	Moderate Buy
Predicted Upside	-9.06% Downside	841.55% Upside	13.05% Upside
News Sentiment Rating	Neutral News See Recent CCRN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/16/2026	Weiss Ratings 5 of 5 stars		Upgrade	Sell (E+) ➝ Sell (D-)
6/8/2026	Barrington Research 3 of 5 stars	Kevin Steinke 3 of 5 stars	Reiterated Rating	Market Perform	$13.25	+0.42%
5/11/2026	Truist Financial 3 of 5 stars	Tobey Sommer 2 of 5 stars	Boost Target	Hold	$10.00 ➝ $13.25	+0.88%
5/8/2026	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Sutherland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/7/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Market Outperform ➝ Market Perform
5/7/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
5/7/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Piccolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Hold	$15.00 ➝ $13.25	+1.57%
3/5/2026	Cross Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Sutherland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$14.00	+44.33%
1/19/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
12/9/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$16.50 ➝ $9.00	+10.57%
The end may be near for these iconic stocks (Ad) Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
12/4/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Slevin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Hold	$8.65	+16.34%
12/4/2024	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Romeo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:19 PM ET.

CCRN Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Cross Country Healthcare is $12.05, with a high forecast of $14.00 and a low forecast of $8.65.

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cross Country Healthcare in the last year. There is currently 1 sell rating and 9 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CCRN shares.

According to analysts, Cross Country Healthcare's stock has a predicted downside of -9.06% based on their 12-month stock forecasts.

Over the previous 90 days, Cross Country Healthcare's stock had 1 upgrade and 1 downgrade by analysts.

Cross Country Healthcare has been rated by research analysts at Barrington Research, and Weiss Ratings in the past 90 days.

Analysts like Cross Country Healthcare less than other "healthcare" companies. The consensus rating for Cross Country Healthcare is Reduce while the average consensus rating for "healthcare" companies is Hold. Learn more on how CCRN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cross Country Healthcare Recommendations

MarketBeat monitors more than a dozen sources for Cross Country Healthcare analyst ratings, with the most recent rating issued on 7/16/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.